Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020473 (
hyperlipidemia
)
15,891
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Benoxaprofen
(
BOP
) is a 2-methyl propionic acid derivative with anti-inflammatory activity.
BOP
has an asymmetric carbon, and receives chiral inversion from R to S in vivo.
BOP
is metabolized to glucuronide (BOP-G) and taurine conjugate (BOP-T). The configuration of
BOP
-G is mainly S, and that of
BOP
-T is R. Chiral inversion of R to S of the propionic acid moiety and amino acid conjugation of carboxyl compounds proceed via an acyl CoA intermediate. It is known that fibrates, used in
hyperlipidemia
, induce acyl CoA synthetase and increase CoA concentration. We administered racemic
BOP
(10 mg/kg body weight) to rats (CFA+) pre-administered clofibric acid (CFA, 280 mg/kg/day), and studied
BOP
,
BOP
-G, and
BOP
-T enantiomer concentrations in plasma and bile up to 12 h after administration. The findings were compared with those in rats (CFA-) that had not received CFA. Furthermore, we studied the amounts of
BOP
-G enantiomer produced by glucuronidation in vitro using microsomes pretreated with CFA. The amounts of (S)-
BOP
-G in CFA+ rats were 2.7-fold larger than that in CFA- rats. Although (R)-
BOP
-T was excreted in CFA- rats,
BOP
-T could not be detected in CFA+ rats. Plasma clearance values of racemic
BOP
and (S)-
BOP
in CFA+ rats were 5-fold and 6-fold larger than those in CFA- rats, respectively. (S)-
BOP
-G formation activities were higher than (R)-
BOP
-G formation activities in both CFA+and CFA- microsomes. These findings suggest that CFA increases biliary excretion of (S)-
BOP
-G and facilitates plasma elimination of
BOP
, and further suggests that CFA predominantly induces chiral inversion to S rather than metabolic reaction to (R)-
BOP
-T, resulting in an increase of (S)-
BOP
-G.
...
PMID:Effects of clofibric acid on the biliary excretion of benoxaprofen glucuronide and taurine conjugate in rats. 2202 60